Extracorporeal Photopheresis and Adjuvant Aerosolized Granulocyte-Macrophage Colony-Stimulating Factor for Sézary Syndrome Saskia A. Bouwhuis, MD, Svetomir N. Markovic, MD, PhD, Marian T. McEvoy, MD, Mark R. Pittelkow, MD Mayo Clinic Proceedings Volume 77, Issue 2, Pages 197-200 (February 2002) DOI: 10.4065/77.2.197 Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 1 Patient with cutaneous T-cell lymphoma, Sezary syndrome, showing alopecia, ectropion, and erythema of facial skin Mayo Clinic Proceedings 2002 77, 197-200DOI: (10.4065/77.2.197) Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 2 Generalized bright erythema of abdominal skin. Mayo Clinic Proceedings 2002 77, 197-200DOI: (10.4065/77.2.197) Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 3 Marked improvement of skin after treatment with aerosolized granulocyte-macrophage colony-stimulating factor. Mayo Clinic Proceedings 2002 77, 197-200DOI: (10.4065/77.2.197) Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 4 Absolute Sezary cell count before, during, and after therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF). Mayo Clinic Proceedings 2002 77, 197-200DOI: (10.4065/77.2.197) Copyright © 2002 Mayo Foundation for Medical Education and Research Terms and Conditions